Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Protego-PD
Therapeutic Area : Gastroenterology
Study Phase : IND Enabling
Sponsor : National Institutes of Health
Deal Size : $1.7 million
Deal Type : Funding
Details : This award will fund the potency and preclinical effectiveness milestones for an Investigational New Drug (IND) filing for Protego-PDTM, an orally delivered acellular biotherapeutic developed by Plakous from post-delivery placentas.
Product Name : Protego-PD
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
August 07, 2020
Lead Product(s) : Protego-PD
Therapeutic Area : Gastroenterology
Highest Development Status : IND Enabling
Sponsor : National Institutes of Health
Deal Size : $1.7 million
Deal Type : Funding
Reset All
